• bg-slide1


Drawing on its in-depth knowledge of allergic diseases, and its unique expertise in allergy immunotherapy (AIT) for more than 50 years, Stallergenes thereby offers a comprehensive approach to improving the lives of allergy patients. Patient expectations are at the core of Stallergenes innovation strategy. World leader in sublingual immunotherapy, Stallergenes provides efficient and patient-friendly allergy immunotherapy treatment options, such as shorter protocols to reduce the duration of treatment and the new convenient tablet form.